These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8629127)

  • 1. Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
    Tang-naitrisorana Y; Issaragrisil S; Visuthisakchai S; Suvatte V; Piankijakum A
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():291-5. PubMed ID: 8629127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of peripheral blood stem cell transplant with bone marrow transplant in class 3 thalassemic patients.
    Iravani M; Tavakoli E; Babaie MH; Ashouri A; Khatami F; Ghavamzadeh A
    Exp Clin Transplant; 2010 Mar; 8(1):66-73. PubMed ID: 20199374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow transplantation for beta-thalassemia major].
    Zhu W; Yang M; Xing X; He Y; Zhuang X; Guan G; Qian X; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):79-81. PubMed ID: 10751525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic progenitor cells in the blood and bone marrow in various hematologic disorders.
    Issaragrisil S; U-pratya Y; Yimyam M; Pakdeesuwan K; Khuhapinant A; Muangsup W; Pattanapanyasat K
    Stem Cells; 1998; 16 Suppl 1():123-8. PubMed ID: 11012154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for thalassemia in Thailand.
    Issaragrisil S; Visudhisakchai S; Suvatte V; Chandanayingyong D; Piankijagum A; Mahasandana C; Tanphaichitr VS
    Bone Marrow Transplant; 1993; 12 Suppl 1():42-4. PubMed ID: 8374559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
    Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C
    Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematopoietic stem cell transplantation for beta-thalassemia major].
    Zhu W; Yang M; He Y
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):265-7. PubMed ID: 11798768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated bone marrow transplantation for beta-thalassemia major: report of the first 2 successful cases in Asia.
    Zhu WG; Feng ZC; Li QP; Zhong CX; Li ZD; Lu ZG
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):281-2. PubMed ID: 12651255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
    Ruiz-Argüelles GJ; Gómez-Almaguer D; Ruiz-Argüelles A; González-Llano O; Cantú OG; Jaime-Pérez JC
    Am J Hematol; 2001 Apr; 66(4):241-4. PubMed ID: 11279633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
    Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
    Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
    Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral blood hematopoietic cell transplant using immunosuppressive chemotherapy without bone marrow destruction: "minitransplant"].
    Gómez-Almaguer D; Ruiz-Argüelles GJ; González-Llano O; Ruiz-Argüelles A; Cantú-Rodríguez OG
    Gac Med Mex; 2002; 138(3):235-9. PubMed ID: 12096391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
    Iravani M; Mousavi A; Gholibeikian S; Bahar B; Samiee S; Ashouri A; Eghbal L; Ghavamzadeh A
    Bone Marrow Transplant; 2005 Jun; 35(11):1095-9. PubMed ID: 15821773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of circulating haemopoietic progenitor cells in the early phase of haemopoietic reconstitution after autologous and allogeneic bone marrow transplantation.
    Kwong YL; Millar JL; Powles RL
    Bone Marrow Transplant; 1989 Sep; 4(5):575-8. PubMed ID: 2790335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.